-
1
-
-
0033773642
-
Concordance of infl ammatory bowel disease among Danish twins. Results of a nationwide study
-
Orholm M, Binder V, Sørensen TI et al. Concordance of infl ammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 2000; 35: 1075-81.
-
(2000)
Scand J Gastroenterol
, vol.35
, pp. 1075-1081
-
-
Orholm, M.1
Binder, V.2
Sørensen, T.I.3
-
2
-
-
0038620498
-
Infl ammatory bowel disease in a Swedish twin cohort: A long-term follow-up of concordance and clinical characteristics
-
Halfvarson J, Bodin L, Tysk C et al. Infl ammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003; 124: 1767-73.
-
(2003)
Gastroenterology
, vol.124
, pp. 1767-1773
-
-
Halfvarson, J.1
Bodin, L.2
Tysk, C.3
-
3
-
-
79955561083
-
Epidemiology and natural history of infl ammatory bowel diseases
-
Cosnes J, Gower-Rousseau C, Seksik P et al. Epidemiology and natural history of infl ammatory bowel diseases. Gastroenterology 2011; 140: 1785-94.
-
(2011)
Gastroenterology
, vol.140
, pp. 1785-1794
-
-
Cosnes, J.1
Gower-Rousseau, C.2
Seksik, P.3
-
4
-
-
34249010216
-
Contribution of genetic and environmental factors in the pathogenesis of Crohn's disease in a large family with multiple cases
-
Joossens M, Simoens M, Vermeire S et al. Contribution of genetic and environmental factors in the pathogenesis of Crohn's disease in a large family with multiple cases. Infl amm Bowel Dis 2007; 13: 580-4.
-
(2007)
Infl Amm Bowel Dis
, vol.13
, pp. 580-584
-
-
Joossens, M.1
Simoens, M.2
Vermeire, S.3
-
5
-
-
0035869415
-
Appendectomy and protection against ulcerative colitis
-
Andersson RE, Olaison G, Tysk C et al. Appendectomy and protection against ulcerative colitis. N Engl J Med 2001; 344: 808-14.
-
(2001)
N Engl J Med
, vol.344
, pp. 808-814
-
-
Andersson, R.E.1
Olaison, G.2
Tysk, C.3
-
6
-
-
0037221708
-
Appendectomy is followed by increased risk of Crohn's disease
-
Andersson RE, Olaison G, Tysk C et al. Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology 2003; 124: 40-6.
-
(2003)
Gastroenterology
, vol.124
, pp. 40-46
-
-
Andersson, R.E.1
Olaison, G.2
Tysk, C.3
-
7
-
-
33750610190
-
Smoking and infl ammatory bowel disease: A meta-analysis
-
Mahid SS, Minor KS, Soto RE et al. Smoking and infl ammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006; 81: 1462-71.
-
(2006)
Mayo Clin Proc
, vol.81
, pp. 1462-1471
-
-
Mahid, S.S.1
Minor, K.S.2
Soto, R.E.3
-
8
-
-
84857533986
-
Higher predicted Vitamin D status is associated with reduced risk of Crohn's disease
-
Ananthakrishnan AN, Khalili H, Higuchi LM et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 2012; 142: 482-9.
-
(2012)
Gastroenterology
, vol.142
, pp. 482-489
-
-
Ananthakrishnan, A.N.1
Khalili, H.2
Higuchi, L.M.3
-
9
-
-
84886794916
-
A prospective study of long-term intake of dietary fi ber and risk of Crohn's disease and ulcerative colitis
-
Ananthakrishnan AN, Khalili H, Konijeti GG et al. A prospective study of long-term intake of dietary fi ber and risk of Crohn's disease and ulcerative colitis. Gastroenterology 2013; 145: 970-7.
-
(2013)
Gastroenterology
, vol.145
, pp. 970-977
-
-
Ananthakrishnan, A.N.1
Khalili, H.2
Konijeti, G.G.3
-
11
-
-
84909958892
-
Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: A meta-analysis
-
Ungaro R, Bernstein CN, Gearry R et al. Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol 2014; 109: 1728-38.
-
(2014)
Am J Gastroenterol
, vol.109
, pp. 1728-1738
-
-
Ungaro, R.1
Bernstein, C.N.2
Gearry, R.3
-
12
-
-
50649119301
-
The risk of oral contraceptives in the etiology of infl ammatory bowel disease: A meta-analysis
-
Cornish JA, Tan E, Simillis C et al. The risk of oral contraceptives in the etiology of infl ammatory bowel disease: a meta-analysis. Am J Gastroenterol 2008; 103: 2394-400.
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 2394-2400
-
-
Cornish, J.A.1
Tan, E.2
Simillis, C.3
-
13
-
-
84868103886
-
Hormone therapy increases risk of ulcerative colitis but not Crohn's disease
-
Khalili H, Higuchi LM, Ananthakrishnan AN et al. Hormone therapy increases risk of ulcerative colitis but not crohn's disease. Gastroenterology 2012; 143: 1199-206.
-
(2012)
Gastroenterology
, vol.143
, pp. 1199-1206
-
-
Khalili, H.1
Higuchi, L.M.2
Ananthakrishnan, A.N.3
-
14
-
-
77953991788
-
Isotretinoin use and the risk of infl ammatory bowel disease: A case-control study
-
Crockett SD, Porter CQ, Martin CF et al. Isotretinoin use and the risk of infl ammatory bowel disease: a case-control study. Am J Gastroenterol 2010; 105: 1986-93.
-
(2010)
Am J Gastroenterol
, vol.105
, pp. 1986-1993
-
-
Crockett, S.D.1
Porter, C.Q.2
Martin, C.F.3
-
15
-
-
84874227785
-
Isotretinoin and risk for infl ammatory bowel disease: A nested case-control study and meta-analysis of published and unpublished data
-
Etminan M, Bird ST, Delaney JA et al. Isotretinoin and risk for infl ammatory bowel disease: A nested case-control study and meta-analysis of published and unpublished data. JAMA Dermatol. 2013; 149: 216-20.
-
(2013)
JAMA Dermatol.
, vol.149
, pp. 216-220
-
-
Etminan, M.1
Bird, S.T.2
Delaney, J.A.3
-
16
-
-
80052030390
-
Aspirin in the aetiology of Crohn's disease and ulcerative colitis: A european prospective cohort study
-
Chan SS, Luben R, Bergmann MM et al. Aspirin in the aetiology of crohn's disease and ulcerative colitis: A european prospective cohort study. Aliment Pharmacol Ther 2011; 34: 649-55.
-
(2011)
Aliment Pharmacol Ther
, vol.34
, pp. 649-655
-
-
Chan, S.S.1
Luben, R.2
Bergmann, M.M.3
-
17
-
-
84857740500
-
Aspirin, nonsteroidal anti-infl ammatory drug use, and risk for Crohn disease and ulcerative colitis: A cohort study
-
Ananthakrishnan AN, Higuchi LM, Huang ES et al. Aspirin, nonsteroidal anti-infl ammatory drug use, and risk for crohn disease and ulcerative colitis: A cohort study. Ann Intern Med 2012; 156: 350-9.
-
(2012)
Ann Intern Med
, vol.156
, pp. 350-359
-
-
Ananthakrishnan, A.N.1
Higuchi, L.M.2
Huang, E.S.3
-
18
-
-
0030913612
-
Non-steroidal anti-infl ammatory drugs are associated wiThemergency admission to hospital for colitis due to infl ammatory bowel disease
-
Evans JM, McMahon AD, Murray FE et al. Non-steroidal anti-infl ammatory drugs are associated wiThemergency admission to hospital for colitis due to infl ammatory bowel disease. Gut 1997; 40: 619-22.
-
(1997)
Gut
, vol.40
, pp. 619-622
-
-
Evans, J.M.1
McMahon, A.D.2
Murray, F.E.3
-
19
-
-
0037444883
-
Non-steroidal anti-infl ammatory drugs, aspirin and newly diagnosed colitis: A case-control study
-
Gleeson MH, Davis AJ. Non-steroidal anti-infl ammatory drugs, aspirin and newly diagnosed colitis: a case-control study. Aliment Pharmacol Ther 2003; 17: 817-25.
-
(2003)
Aliment Pharmacol Ther
, vol.17
, pp. 817-825
-
-
Gleeson, M.H.1
Davis, A.J.2
-
20
-
-
84904497873
-
Non-cardiovascular Effects associated with statins
-
Desai CS, Martin SS, Blumenthal RS. Non-cardiovascular Effects associated with statins. BMJ 2014; 349: g3743.
-
(2014)
BMJ
, vol.349
, pp. g3743
-
-
Desai, C.S.1
Martin, S.S.2
Blumenthal, R.S.3
-
21
-
-
0034948339
-
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
-
Weitz-Schmidt G, Welzenbach K, Brinkmann V et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 2001; 7: 687-92.
-
(2001)
Nat Med
, vol.7
, pp. 687-692
-
-
Weitz-Schmidt, G.1
Welzenbach, K.2
Brinkmann, V.3
-
23
-
-
84860672665
-
Statins are associated with reduced use of steroids in infl ammatory bowel disease: A retrospective cohort study
-
Crockett SD, Hansen R, Stürmer T et al. Statins are associated with reduced use of steroids in infl ammatory bowel disease: a retrospective cohort study. Infl amm Bowel Dis 2012; 18: 1048-56.
-
(2012)
Infl Amm Bowel Dis
, vol.18
, pp. 1048-1056
-
-
Crockett, S.D.1
Hansen, R.2
Stürmer, T.3
-
24
-
-
56749161704
-
Use of atorvastatin as an antiinfl ammatory treatment in Crohn's disease
-
Grip O, Janciauskiene S, Bredberg A. Use of atorvastatin as an antiinfl ammatory treatment in Crohn's disease. Br J Pharmacol 2008; 155: 1085-92.
-
(2008)
Br J Pharmacol
, vol.155
, pp. 1085-1092
-
-
Grip, O.1
Janciauskiene, S.2
Bredberg, A.3
-
25
-
-
65549131046
-
Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn's disease
-
Grip O, Janciauskiene S. Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn's disease. PLoS One 2009; 4: 1-6.
-
(2009)
PLoS One
, vol.4
, pp. 1-6
-
-
Grip, O.1
Janciauskiene, S.2
-
26
-
-
33748945482
-
Atorvastatin decreases Seo Index in patients with short duration of disease in ulcerative colitis: A randomized placebo-controlled clinical\trial
-
Higgins PD, Khan T, Mapili J et al. Atorvastatin decreases Seo Index in patients with short duration of disease in ulcerative colitis: A randomized placebo-controlled clinical\trial. Gastroenterology 2006; 130: A120.
-
(2006)
Gastroenterology
, vol.130
, pp. A120
-
-
Higgins, P.D.1
Khan, T.2
Mapili, J.3
-
27
-
-
84922703915
-
A nationwide 2010-2012 analysis of U. S. Health care utilization in infl ammatory bowel diseases
-
vanDeen WK, van Oijen MGH, Myers KD et al. A nationwide 2010-2012 analysis of U. S. health care utilization in infl ammatory bowel diseases. Infl amm Bowel Dis 2014; 20: 1747-53.
-
(2014)
Infl Amm Bowel Dis
, vol.20
, pp. 1747-1753
-
-
VanDeen, W.K.1
Van Oijen, M.G.H.2
Myers, K.D.3
-
28
-
-
82955251005
-
Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis
-
Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics and new diagnoses of crohn's disease and ulcerative colitis. Am J Gastroenterol 2011; 106: 2133-42.
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 2133-2142
-
-
Shaw, S.Y.1
Blanchard, J.F.2
Bernstein, C.N.3
-
29
-
-
84869788946
-
Metformin and the risk of cancer: Time-related biases in observational studies
-
Suissa S, Azoulay L. Metformin and the risk of cancer: time-related biases in observational studies. Diabetes Care 2012; 35: 2665-73.
-
(2012)
Diabetes Care
, vol.35
, pp. 2665-2673
-
-
Suissa, S.1
Azoulay, L.2
-
30
-
-
84951569622
-
Understanding and avoiding immortal-time bias in gastrointestinal observational research
-
Targownik LE, Suissa S. Understanding and avoiding immortal-time bias in gastrointestinal observational research. Am J Gastroenterol 2015; 110: 1647-50.
-
(2015)
Am J Gastroenterol
, vol.110
, pp. 1647-1650
-
-
Targownik, L.E.1
Suissa, S.2
-
31
-
-
84867173210
-
Antibiotic exposure and IBD development among children: A population-based cohort study
-
Kronman MP, Zaoutis TE, Haynes K et al. Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics 2012; 130: e794-803.
-
(2012)
Pediatrics
, vol.130
, pp. e794-803
-
-
Kronman, M.P.1
Zaoutis, T.E.2
Haynes, K.3
-
32
-
-
84859728797
-
Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease-a nationwide, register-based Finnish case-control study
-
Virta L, Auvinen A, Helenius H et al. Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease-a nationwide, register-based Finnish case-control study. Am J Epidemiol 2012; 175: 775-84.
-
(2012)
Am J Epidemiol
, vol.175
, pp. 775-784
-
-
Virta, L.1
Auvinen, A.2
Helenius, H.3
-
33
-
-
84902576469
-
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
-
Stone NJ, Robinson JG, Lichtenstein AH et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2889-934.
-
(2014)
J Am Coll Cardiol
, vol.63
, pp. 2889-2934
-
-
Stone, N.J.1
Robinson, J.G.2
Lichtenstein, A.H.3
-
35
-
-
84868103886
-
Hormone therapy increases risk of ulcerative colitis but not Crohn's disease
-
Khalili H, Higuchi LM, Ananthakrishnan AN et al. Hormone therapy increases risk of ulcerative colitis but not Crohn's disease. Gastroenterology 2012; 143: 1199-206.
-
(2012)
Gastroenterology
, vol.143
, pp. 1199-1206
-
-
Khalili, H.1
Higuchi, L.M.2
Ananthakrishnan, A.N.3
-
36
-
-
84880321582
-
Oral contraceptives, reproductive factors and risk of infl ammatory bowel disease
-
Khalili H, Higuchi LM, Ananthakrishnan AN et al. Oral contraceptives, reproductive factors and risk of infl ammatory bowel disease. Gut 2013; 62: 1153-9.
-
(2013)
Gut
, vol.62
, pp. 1153-1159
-
-
Khalili, H.1
Higuchi, L.M.2
Ananthakrishnan, A.N.3
-
37
-
-
84928584490
-
Comparison of frequency of infl ammatory bowel disease and noninfectious gastroenteritis among statin users versus nonusers
-
Khalil D, Boktor M, Mortensen EM et al. Comparison of frequency of infl ammatory bowel disease and noninfectious gastroenteritis among statin users versus nonusers. Am J Cardiol 2015; 115: 1396-401.
-
(2015)
Am J Cardiol
, vol.115
, pp. 1396-1401
-
-
Khalil, D.1
Boktor, M.2
Mortensen, E.M.3
-
38
-
-
84906789715
-
Statins: From cholesterol-lowering drugs to novel immunomodulators for the treatment of Th 17-mediated autoimmune diseases
-
Ulivieri C, Baldari CT. Statins: from cholesterol-lowering drugs to novel immunomodulators for the treatment of Th 17-mediated autoimmune diseases. Pharacol Res 2014; 88: 41-52.
-
(2014)
Pharacol Res
, vol.88
, pp. 41-52
-
-
Ulivieri, C.1
Baldari, C.T.2
-
39
-
-
84928609082
-
The impact of statins therapy on disease activity and infl ammatory factor in patients with rheumatoid arthritis: A metaanalysis
-
Lv S, Liu Y, Zou Z et al. The impact of statins therapy on disease activity and infl ammatory factor in patients with rheumatoid arthritis: a metaanalysis. Clin Exp Rheumatol 2015; 33: 69-76.
-
(2015)
Clin Exp Rheumatol
, vol.33
, pp. 69-76
-
-
Lv, S.1
Liu, Y.2
Zou, Z.3
-
40
-
-
2442561768
-
Oral simvastatin treatment in relapsingremitting multiple sclerosis
-
Vollmer T, Key L, Durkalski V et al. Oral simvastatin treatment in relapsingremitting multiple sclerosis. The Lancet 2004; 363: 1607-8.
-
(2004)
The Lancet
, vol.363
, pp. 1607-1608
-
-
Vollmer, T.1
Key, L.2
Durkalski, V.3
-
41
-
-
84906790536
-
Atorvastatin Effect on systemic lupus erythematosus disease activity: A double-blind randomized clinical trial
-
Fatemi A, Moosavi M, Sayedbonakdar Z et al. Atorvastatin Effect on systemic lupus erythematosus disease activity: a double-blind randomized clinical trial. Clin Rheumatol 2014; 33: 1273-8.
-
(2014)
Clin Rheumatol
, vol.33
, pp. 1273-1278
-
-
Fatemi, A.1
Moosavi, M.2
Sayedbonakdar, Z.3
-
42
-
-
78649918795
-
Anti-infl ammatory Effects of Resveratrol, Curcumin and Simvastatin in acute small intestinal infl ammation
-
Bereswill S, Muñoz M, Fischer A et al. Anti-infl ammatory Effects of Resveratrol, Curcumin and Simvastatin in acute small intestinal infl ammation. PLoS One 2010; 5: e15099.
-
(2010)
PLoS One
, vol.5
, pp. e15099
-
-
Bereswill, S.1
Muñoz, M.2
Fischer, A.3
-
43
-
-
0037038402
-
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th 2 bias and reverses paralysis in central nervous system autoimmune disease
-
Youssef S, Stüve O, Patarroyo JC et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th 2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002; 420: 78-84.
-
(2002)
Nature
, vol.420
, pp. 78-84
-
-
Youssef, S.1
Stüve, O.2
Patarroyo, J.C.3
-
44
-
-
33745684509
-
Effects of statins on experimental colitis in normocholesterolemic rats
-
Jahovic N, Gedik N, Ercan F et al. Effects of statins on experimental colitis in normocholesterolemic rats. Scand J Gastroenterol 2006; 41: 954-62.
-
(2006)
Scand J Gastroenterol
, vol.41
, pp. 954-962
-
-
Jahovic, N.1
Gedik, N.2
Ercan, F.3
-
45
-
-
80755143841
-
The Effect of atorvastatin and its role on systemic cytokine network in treatment of acute experimental colitis
-
Aktunc E, Kayhan B, Arasli M et al. The Effect of atorvastatin and its role on systemic cytokine network in treatment of acute experimental colitis. Immunopharmacol Immunotoxicol 2011; 33: 667-75.
-
(2011)
Immunopharmacol Immunotoxicol
, vol.33
, pp. 667-675
-
-
Aktunc, E.1
Kayhan, B.2
Arasli, M.3
-
46
-
-
0037382469
-
The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and infl ammation in dextran-sulfate induced colitis
-
Sasaki M, Bharwani S, Jordan P et al. The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and infl ammation in dextran-sulfate induced colitis. J Pharmacol Exp Ther 2003; 305: 78-85.
-
(2003)
J Pharmacol Exp Ther
, vol.305
, pp. 78-85
-
-
Sasaki, M.1
Bharwani, S.2
Jordan, P.3
-
47
-
-
84857694797
-
Statins as anti-infl ammatory agents in atherogenesis: Molecular mechanisms and lessons from the recent clinical trials
-
Antonopoulos S, Margaritis M, Lee R et al. Statins as anti-infl ammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Des 2012; 18: 1519-30.
-
(2012)
Curr Pharm des
, vol.18
, pp. 1519-1530
-
-
Antonopoulos, S.1
Margaritis, M.2
Lee, R.3
-
50
-
-
44449134283
-
Simvastatin attenuates trinitrobenzene sulfonic acid-induced colitis, but not oxazalone-induced colitis
-
Ikeda M, Takeshima F, Isomoto H et al. Simvastatin attenuates trinitrobenzene sulfonic acid-induced colitis, but not oxazalone-induced colitis. D ig Dis Sci 2 008; 5 3: 1 869-7 5.
-
(2008)
Dig Dis Sci
, vol.53
, pp. 1869-1875
-
-
Ikeda, M.1
Takeshima, F.2
Isomoto, H.3
-
51
-
-
84990987860
-
-
Crohn's and Colitis Foundation of America
-
Crohn's and Colitis Foundation of America. The Facts About Infl ammatory Bowel Disease, 2014. Accessed at http://www. ccfa. org/assets/pdfs/updatedibdfactbook. pdf.
-
(2014)
The Facts about Infl Ammatory Bowel Disease
-
-
-
53
-
-
0031661402
-
Assessing the sensitivity of regression results to unmeasured confounders in observational studies
-
Lin DY, Psaty BM, Kronmal RA. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics 1998; 54: 948-63.
-
(1998)
Biometrics
, vol.54
, pp. 948-963
-
-
Lin, D.Y.1
Psaty, B.M.2
Kronmal, R.A.3
|